EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access

A prospective cohort of men with localized prostate cancer on active surveillance protocol in Hong Kong, China: what did we learn?

Xiaobo Wu, Ivan Ching-Ho Ko, Cindy Yeuk-Lam Hong, Samuel Chi-Hang Yee, Jeremy Yuen-Chun Teoh, Samson Yun-Sang Chan, Ho-Man Tam, Chi-Kwok Chan, Chi-Fai Ng, Peter Ka-Fung Chiu

Asian Journal of Andrology · 2024

DOI: 10.4103/aja202373 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Asian Journal of Andrology, 2024. Verfasst von Xiaobo Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: SH Ho Urology Centre, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostate-Specific Antigen, Watchful Waiting, Disease Progression. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to report the outcomes of active surveillance (AS) in the management of low-risk prostate cancer (PCa). It recruited 87 men who were prospectively followed up according to the Prostate Cancer Research International Active Surveillance (PRIAS) protocol with local adaptation at SH Ho Urology Centre, Prince of Wales Hospital, Hong Kong, China. We investigated the predictors of disease progression and found that baseline prostate-specific antigen density (PSAD) and the presence of the highest Prostate Imaging-Reporting and Data System (PI-RADS) score 5 lesion on magnetic resonance imaging (MRI) are significantly correlated with disease progression. Moreover, men with PSAD >0.2 ng ml −2 or PI-RADS 4 or 5 lesions had significantly worse upgrading-free survival compared to those with PSAD ≤0.2 ng ml −2 and PI-RADS 2 or 3 lesions. The study concludes that AS is a safe and effective management strategy for selected patients to defer radical treatment and that most disease progression can be detected after the first repeated biopsy. The combination of PSAD >0.2 ng ml −2 and PI-RADS 4 or 5 lesions may serve as a useful predictor of early disease progression and provide a guide to optimize follow-up protocols for men in different risk groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstate-Specific AntigenWatchful WaitingDisease ProgressionMagnetic Resonance ImagingHumansMaleHong KongMiddle AgedProspective StudiesAgedProstateBiopsy

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • SH Ho Urology Centre, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.

Zitieren

APA

Wu, X., Ko, I. C., Hong, C. Y., Yee, S. C., Teoh, J. Y., Chan, S. Y., Tam, H. M., Chan, C. K., Ng, C. F., & Chiu, P. K. (2024). A prospective cohort of men with localized prostate cancer on active surveillance protocol in Hong Kong, China: what did we learn?. Asian Journal of Andrology. https://doi.org/10.4103/aja202373

Vancouver

Wu X, Ko IC, Hong CY, Yee SC, Teoh JY, Chan SY, et al. A prospective cohort of men with localized prostate cancer on active surveillance protocol in Hong Kong, China: what did we learn?. Asian Journal of Andrology. 2024. doi:10.4103/aja202373

BibTeX
@article{Wu2024,
  author = {Wu, Xiaobo and Ko, Ivan Ching-Ho and Hong, Cindy Yeuk-Lam and Yee, Samuel Chi-Hang and Teoh, Jeremy Yuen-Chun and Chan, Samson Yun-Sang and Tam, Ho-Man and Chan, Chi-Kwok and Ng, Chi-Fai and Chiu, Peter Ka-Fung},
  title = {A prospective cohort of men with localized prostate cancer on active surveillance protocol in Hong Kong, China: what did we learn?},
  journal = {Asian Journal of Andrology},
  year = {2024},
  doi = {10.4103/aja202373}
}
Kostenlos starten →